Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunityBio, Inc. | Chief Financial Officer | Common Stock | 186K | $624K | $3.36 | Jan 31, 2024 | Direct |
ImmunityBio, Inc. | Chief Financial Officer | Restricted Stock Units | 122K | $493K | $4.04 | Feb 22, 2024 | Direct |
ImmunityBio, Inc. | Chief Financial Officer | Stock Option (right to buy) | 424K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IBRX | ImmunityBio, Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Jan 31, 2024 | 3 | -$90.2K | 4 | Feb 2, 2024 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Dec 31, 2023 | 3 | -$52.8K | 4 | Jan 3, 2024 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Sep 1, 2023 | 2 | $0 | 4 | Sep 6, 2023 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Aug 25, 2023 | 1 | $0 | 4 | Aug 28, 2023 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Dec 31, 2022 | 2 | $0 | 4 | Jan 4, 2023 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Mar 23, 2022 | 2 | $0 | 4 | Mar 25, 2022 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Dec 9, 2021 | 2 | $0 | 4 | Dec 13, 2021 | Chief Financial Officer |
IBRX | ImmunityBio, Inc. | Sep 9, 2021 | 2 | $0 | 4 | Sep 13, 2021 | Chief Financial Officer |